SCHEMBL19288667

SCHEMBL19288667

COc1cc(N2CCP(C)(=O)CC2)ccc1NC1=NC(Nc2ncc(C(C)C)o2)=NCC1Cl

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALK Q9UM73 16/20 0.37
▸ INSR P06213 2/20 0.37
▸ LRRK2 Q5S007 3/20 0.36
▸ MAPK9 P45984 2/20 0.34
▸ MAPK10 P53779 2/20 0.34
▸ ZAP70 P43403 1/20 0.34
▸ DCLK1 O15075 2/20 0.34
▸ CDC7 O00311 1/20 0.34
▸ PLK4 O00444 1/20 0.34
▸ CHEK1 O14757 1/20 0.34
▸ AURKA O14965 1/20 0.34
▸ PDPK1 O15530 1/20 0.34
▸ DAPK3 O43293 1/20 0.34
▸ DYRK3 O43781 1/20 0.34
▸ JAK2 O60674 1/20 0.34
▸ PRKD3 O94806 1/20 0.34
▸ PAK4 O96013 1/20 0.34
▸ CHEK2 O96017 1/20 0.34
▸ EGFR P00533 1/20 0.34
▸ ERBB2 P04626 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11916333 0.79 ALK (0.60) ALKINSRLRRK2ZAP70EGFR
SCHEMBL17527282 0.71 ALK (0.60) ALKINSRLRRK2IGF1R
SCHEMBL19288509 0.71 ALK (0.32) ALKINSRZAP70JAK2EGFR
SCHEMBL1493535 0.67 ALK (0.60) ALKINSRLRRK2
SCHEMBL15206515 0.65 ALK (0.63) ALKINSRLRRK2MAPK9MAPK10
SCHEMBL11900623 0.64 ALK (0.34) ALKINSRLRRK2
SCHEMBL11901894 0.63 ALK (0.59) ALKINSRLRRK2CHEK1AURKA
SCHEMBL11916458 0.61 ALK (0.80) ALKINSRLRRK2MAPK9MAPK10
SCHEMBL19288535 0.61 ALK (0.56) ALKINSRLRRK2ZAP70EGFR
SCHEMBL1493647 0.61 ALK (0.61) ALKINSRLRRK2CHEK1AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3210609-A1 PHOSPHOROUS DERIVATIVES AS KINASE INHIBITORS ARIAD PHARMACEUTICALS, INC. (US) 2017-08-30 — — EP disclosed
Send feedback